Advances in cancer immunotherapy
Authors:
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 20 (2) , 63-65
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell LysisJournal of Experimental Medicine, 1998
- A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cellNature, 1998
- Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responsesImmunology Today, 1998
- Dendritic cells and the control of immunityNature, 1998
- p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell ActivationJournal of Experimental Medicine, 1997
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.Journal of Experimental Medicine, 1996
- Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunityNature Medicine, 1995
- From defined human tumor antigens to effective immunization?Immunology Today, 1995
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991